Detailed answers about ELYSIAN MEDICAL AESTHETICS CLINIC LTD, including incorporation, status, business activity, and accounts information.
When was ELYSIAN MEDICAL AESTHETICS CLINIC LTD founded?
ELYSIAN MEDICAL AESTHETICS CLINIC LTD was officially incorporated on 8 June 2025 and is registered under company number 16503029. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ELYSIAN MEDICAL AESTHETICS CLINIC LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ELYSIAN MEDICAL AESTHETICS CLINIC LTD?
ELYSIAN MEDICAL AESTHETICS CLINIC LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ELYSIAN MEDICAL AESTHETICS CLINIC LTD do?
ELYSIAN MEDICAL AESTHETICS CLINIC LTD operates in the following sectors: 86220 - Specialists medical practice activities, 86900 - Other human health activities, 96020 - Hairdressing and other beauty treatment, 96040 - Physical well-being activities. These SIC codes provide insight into the company's business activities and industry focus.
What is ELYSIAN MEDICAL AESTHETICS CLINIC LTD's registered address?
The registered office address of ELYSIAN MEDICAL AESTHETICS CLINIC LTD is 15 SUNFLOWER AVENUE, MARCH, CAMBRIDGESHIRE, ENGLAND, PE15 9TN. This is the official address filed with Companies House for legal and statutory correspondence.
Is ELYSIAN MEDICAL AESTHETICS CLINIC LTD financially stable?
Financial accounts for ELYSIAN MEDICAL AESTHETICS CLINIC LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.